AnalystsChristopher JamesChristopher James's Stock Forecasts
AnalystsChristopher James
Sectors:
Analyst Ranking
Bottom 34%
#3312 out of 4989 analysts
Average Return
-2.5%
Win Rate
50%1 out of 2
Risk vs Reward
Poor
Good
Christopher James's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Intra Cellular Therapies IncITCI | +19.63% | $18.29 | $21.88 | 2017‑08‑29 - 2018‑08‑30 | Strong Buy |
Christopher James Analyst Color
Get additional color on Christopher James's coverage of popular stocks
Christopher James's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Intra Cellular Therapies IncITCI | 2 | Strong Buy | N/A | N/A | Upgrades | 8 years ago |
Biocryst Pharmaceuticals IncBCRX | 1 | Strong Buy | $11.00 | N/A | Initiates Coverage On | 9 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.